Pelican Therapeutics
LinkedIn

Heat Biologics, Inc. Heat Biologics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • ImPACT
    • ComPACT
    • Pelican’s PTX-35 Co-stimulatory Antibody
    • Scientific Publications
  • Product Pipeline
    • Overview
    • HS-110
    • HS-130
    • PTX-35
    • Expanded Access
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • News Releases
    • Events
  • Contact
    • Overview
    • Careers
  • Pelican Therapeutics

Presentations

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • Company Information

  • Overview
  • Presentations
  • Management Team
  • Contacts
  • FAQ
Corporate Presentation

Corporate Presentation

Jan 8, 2019
Analyst/Investor Day Presentation

Analyst/Investor Day Presentation

Feb 28, 2018
RSS
© 2019 Heat Biologics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap LinkedIn